Welcure Drugs & Pharmaceuticals' penny stock surged 660% over five years and 164% in two years. It hit a 5% upper circuit on ...

President Donald Trump has given major pharmaceutical companies 60 days to slash prescription drug prices or face action.

Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.

As prescription drug prices continue to rise, many patients are left wondering how their costs are determined.

Average selling prices of Illuccix will likely decrease when its transitional pass-through payment status expires in 2025.

Pfizer Inc. reports its Q2 earnings soon, carrying the weight of a 10% stock dip this year. The company, known for its ...

Days after he sent letters instructing top pharmaceutical manufacturers to use a “most favored nation” pricing model for ...

Swiss generic drug manufacturer Sandoz plans to launch unbranded weight-loss drugs in Canada at discounts of up to 70% compared to branded versions once patents begin to expire next year, CEO Richard ...

Bristol Myers Squibb offers a 5.6% dividend yield, strong cash flow, and AI-driven growth potential. See why I see this as a ...

President Trump discusses plans to dramatically cut drug prices, matching the lowest rates worldwide and promising ...

Thousands of Medicare recipients will face higher costs for expensive cancer drugs following passage of two provisions in the One Big Beautiful Bill Act, signed by President Donald Trump in July, The ...